Aaron S. Meadows

434 total citations
13 papers, 383 citations indexed

About

Aaron S. Meadows is a scholar working on Physiology, Genetics and Genetics. According to data from OpenAlex, Aaron S. Meadows has authored 13 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 7 papers in Genetics and 5 papers in Genetics. Recurrent topics in Aaron S. Meadows's work include Lysosomal Storage Disorders Research (7 papers), Virus-based gene therapy research (6 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Aaron S. Meadows is often cited by papers focused on Lysosomal Storage Disorders Research (7 papers), Virus-based gene therapy research (6 papers) and Neurogenetic and Muscular Disorders Research (5 papers). Aaron S. Meadows collaborates with scholars based in United States. Aaron S. Meadows's co-authors include Haiyan Fu, Douglas M. McCarty, Darren Murrey, F. Jason Duncan, Bartholomew J. Naughton, Kim L. McBride, Kevin M. Flanigan, Kimberly Zaraspe, Peter White and William G. Bremer and has published in prestigious journals such as Molecular Therapy, Journal of Alzheimer s Disease and Molecular Therapy — Methods & Clinical Development.

In The Last Decade

Aaron S. Meadows

13 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron S. Meadows United States 11 189 178 176 86 55 13 383
Kimberly Zaraspe United States 5 183 1.0× 192 1.1× 145 0.8× 68 0.8× 61 1.1× 8 335
Alisa A. Shaimardanova Russia 8 257 1.4× 176 1.0× 121 0.7× 50 0.6× 38 0.7× 13 426
Scott Sproul United States 5 344 1.8× 227 1.3× 149 0.8× 68 0.8× 30 0.5× 17 461
Sara Marcó Spain 11 239 1.3× 240 1.3× 368 2.1× 148 1.7× 109 2.0× 14 580
Ayn Schneider United States 6 187 1.0× 250 1.4× 262 1.5× 107 1.2× 71 1.3× 7 459
Kirsten E. Coleman United States 10 211 1.1× 184 1.0× 84 0.5× 37 0.4× 34 0.6× 14 333
Kerry O. Cresawn United States 8 241 1.3× 136 0.8× 208 1.2× 67 0.8× 54 1.0× 9 438
Luca Maggioni Spain 5 141 0.7× 156 0.9× 168 1.0× 77 0.9× 60 1.1× 7 321
Sandra Motas Spain 6 150 0.8× 146 0.8× 215 1.2× 94 1.1× 68 1.2× 6 359
Martina Cesani Italy 12 290 1.5× 169 0.9× 220 1.3× 107 1.2× 38 0.7× 12 540

Countries citing papers authored by Aaron S. Meadows

Since Specialization
Citations

This map shows the geographic impact of Aaron S. Meadows's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron S. Meadows with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron S. Meadows more than expected).

Fields of papers citing papers by Aaron S. Meadows

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron S. Meadows. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron S. Meadows. The network helps show where Aaron S. Meadows may publish in the future.

Co-authorship network of co-authors of Aaron S. Meadows

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron S. Meadows. A scholar is included among the top collaborators of Aaron S. Meadows based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron S. Meadows. Aaron S. Meadows is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Meadows, Aaron S., et al.. (2019). Threshold for Pre-existing Antibody Levels Limiting Transduction Efficiency of Systemic rAAV9 Gene Delivery: Relevance for Translation. Molecular Therapy — Methods & Clinical Development. 13. 453–462. 28 indexed citations
2.
Fu, Haiyan, et al.. (2018). Targeting Root Cause by Systemic scAAV9-hIDS Gene Delivery: Functional Correction and Reversal of Severe MPS II in Mice. Molecular Therapy — Methods & Clinical Development. 10. 327–340. 16 indexed citations
3.
4.
5.
6.
Velazquez, Victoria M., et al.. (2017). Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting. Molecular Therapy — Methods & Clinical Development. 4. 159–168. 36 indexed citations
7.
Fu, Haiyan, et al.. (2017). Serum global metabolomics profiling reveals profound metabolic impairments in patients with MPS IIIA and MPS IIIB. Metabolic Brain Disease. 32(5). 1403–1415. 17 indexed citations
8.
Fu, Haiyan, Marcela P. Cataldi, Kimberly Zaraspe, et al.. (2016). Functional correction of neurological and somatic disorders at later stages of disease in MPS IIIA mice by systemic scAAV9-hSGSH gene delivery. Molecular Therapy — Methods & Clinical Development. 3. 16036–16036. 51 indexed citations
9.
Meadows, Aaron S., F. Jason Duncan, Marybeth Camboni, et al.. (2015). A GLP-Compliant Toxicology and Biodistribution Study: Systemic Delivery of an rAAV9 Vector for the Treatment of Mucopolysaccharidosis IIIB. PubMed. 26(4). 228–242. 20 indexed citations
10.
Duncan, F. Jason, Bartholomew J. Naughton, Kimberly Zaraspe, et al.. (2015). Broad Functional Correction of Molecular Impairments by Systemic Delivery of scAAVrh74-hSGSH Gene Delivery in MPS IIIA Mice. Molecular Therapy. 23(4). 638–647. 23 indexed citations
11.
Murrey, Darren, Bartholomew J. Naughton, F. Jason Duncan, et al.. (2014). Feasibility and Safety of Systemic rAAV9-h NAGLU Delivery for Treating Mucopolysaccharidosis IIIB: Toxicology, Biodistribution, and Immunological Assessments in Primates. PubMed. 25(2). 72–84. 83 indexed citations
12.
Murrey, Darren, Bartholomew J. Naughton, F. Jason Duncan, et al.. (2014). Feasibility and Safety of Systemic rAAV9-hNAGLU Delivery for Treating MPS IIIB: Toxicology, Bio-distribution and Immunological Assessments in Primates. 776275620–776275620. 6 indexed citations
13.
Naughton, Bartholomew J., F. Jason Duncan, Darren Murrey, et al.. (2014). Blood Genome-Wide Transcriptional Profiles Reflect Broad Molecular Impairments and Strong Blood-Brain Links in Alzheimer's Disease. Journal of Alzheimer s Disease. 43(1). 93–108. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kimberly Zaraspe Breakdown of academic impact, for papers by Alisa A. Shaimardanova Breakdown of academic impact, for papers by Scott Sproul Breakdown of academic impact, for papers by Sara Marcó Breakdown of academic impact, for papers by Ayn Schneider Breakdown of academic impact, for papers by Kirsten E. Coleman Breakdown of academic impact, for papers by Kerry O. Cresawn Breakdown of academic impact, for papers by Luca Maggioni Breakdown of academic impact, for papers by Sandra Motas Breakdown of academic impact, for papers by Martina Cesani
Rankless by CCL
2026